TAM
AMRX icon

THB Asset Management’s Amneal Pharmaceuticals AMRX Stock Holding History

THB Asset Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$4.64M Buy
1,014,495
+181,391
+22% +$804K 1.05% 28
2020
Q3 		$3.23M Buy
833,104
+181,954
+28% +$778K 0.9% 40
2020
Q2 		$3.1M Buy
+651,150
New +$2.68M 0.9% 44

Other funds holding AMRX

FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

THB Asset Management's AMRX Position: Q4 2020 in Review

THB Asset Management increased its Amneal Pharmaceuticals (AMRX) stake by 22% in Q4 2020, buying an estimated $804K and bringing the position to 1,014,495 shares worth $4.64M. The position accounts for 1.05% of the portfolio, ranked #28.

THB Asset Management first reported a position in AMRX in Q2 2020 and has held it in 3 quarters since. 133 funds tracked by Wall St. Rank hold AMRX as of Q4 2020.

  • THB Asset Management held 1,014,495 shares of Amneal Pharmaceuticals worth $4.64M as of Q4 2020.
  • THB Asset Management bought 181,391 Amneal Pharmaceuticals shares in Q4 2020, an estimated $804K.
  • Amneal Pharmaceuticals made up 1.05% of THB Asset Management's portfolio in Q4 2020, its #28 holding.
  • THB Asset Management first reported a position in Amneal Pharmaceuticals in Q2 2020 and has held it in 3 quarters since.
  • 133 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q4 2020.

Based on THB Asset Management's 13F filing for Q4 2020, filed 5 Feb 2021.